Anti-Human MMP-14 (MT1-MMP)

Anti-Human MMP-14 (MT1-MMP)

Product No.: M1089

[product_table name="All Top" skus="M1089"]

- -
- -
Formats AvailableView All
Product Type
Monoclonal Antibody
Alternate Names
IgG1 κ

- -
- -
Select Product Size
- -
- -

Antibody Details

Product Details

Reactive Species
Host Species
A synthetic peptide corresponding to amino acids 160 to 173 of human MMP-14
Product Concentration
1.0 mg/ml
This purified antibody is formulated with no carrier proteins or preservatives added in 0.01 M phosphate buffered saline (PBS) pH 7.4, 150 mM NaCl.
Storage and Handling
This antibody may be stored sterile as received at 2-8°C for up to one month. For longer term storage, aseptically aliquot in working volumes without diluting and store at -80°C. Avoid Repeated Freeze Thaw Cycles.
Country of Origin
Next Day Ambient
Each investigator should determine their own optimal working dilution for specific applications. See directions on lot specific datasheets, as information may periodically change.


Anti-Human MMP-14 (clone M43.266) was produced in mice using a synthetic peptide corresponding to amino acids 160 to 173 of human MMP-14.
Matrix metalloproteinases (MMPs) are a family of enzymes that are responsible for the degradation of extracellular matrix components. Of the eleven proteins reported to date, ten are normally found as soluble molecules. The eleventh, and newest of these proteins, has been named MT-MMP for membrane bound MMP. MT-MMP contains a C-terminal transmembrane domain which allows it to localize to the cell surface. It is also unique from the other members of the MMP family in that it contains an 8 amino acid insert in the catalytic domain. The protein is encoded by a 4.5 kb mRNA species giving rise to a protein with a molecular weight of 60-66 kDa by SDS-PAGE. MT-MMP is responsible for cleaving gelatinase A (MMP-2, 72 kDa Type IV collagenase) to the active form. Evidence exists to suggest that MT-MMP itself requires an activation step which is most likely the result of activity of the membrane plasmin cascade. MT-MMP functions by binding TIMP-2 and then the COOH terminal end of MMP-2 resulting in a 105 kDa trimer which effects the cleavage of pro-MMP-2 to the biologically active form. The order of the binding of pro-MMP-2 and TIMP-2 to MT-MMP is critical as TIMP-2 will also inhibit the activity of MMP-2 when present in a soluble form. Since its discovery, a second form of MT-MMP has been identified resulting in a change in the name of the original protein to MT1-MMP.

Antigen Details

Research Area
Cell Biology

References & Citations

1. Strongin, A. Y. et al. (1995) J. Biol. Chem. 270:5331
2. Takino, T. et al. (1995) J. Biol. Chem. 270:23013
3. Sato, H. et al. (1994) Nature 370:61
4. Cottam, DW. et al. (1993) Intl. J. Oncol. 2:861
5. Stetler-Stevenson, WG. et al. (1993) FASEB J. 7:1434
6. Fridman, R. et al. (1992) J. Biol. Chem. 267:15389
7. Woessner, JF. (1991) FASEB J. 5:2145
8. Goldberg, GI. et al. (1989) Proc. Natl. Acad. Sci. 86:8207
General Western Blot Protocol

Formats Available

- -
- -
Prod No.
Products are for research use only. Not for use in diagnostic or therapeutic procedures.